Pharmaceuticals, testing

In recent years, synthetic methodology has been developed to allow the synthesis of diversified substance libraries mainly for pharmaceutical testing in an automated way using either solid phase or solution chemistry.121 Here, efficiency is also an important goal. 

As performance data has become available on these strains, ICH (1997) has incorporated their use into pharmaceutical testing guidelines in lieu of the second rodent species tests (that is, to replace the long-term mouse bioassay when the traditional rat study has been performed). FDA has stated that they would accept such studies when performed in a validated model. In fact, CBER has accepted such studies as a sole carcinogenicity bioassay in some cases where there was negative traditional genotoxicity data and strong evidence of a lack of a mechanistic basis for concern. 

Crowther, J. B., Validation of Pharmaceutical Test Methods, In Handbook of Modern Pharmaceutical Analysis, Vol. 3, (Ahuja, S. and Scypinski, S., Eds.), Separation Science and Technology, Academic Press, New York, pp. 415 43, 2001. 

The first practical applications are likely to include field cages for cell positioning, inexpensive cell sorters and single cell cultivation depots. But once the basic elements for cell handling have been developed, very many kinds of device will become easy to produce. We can expect to see new systems for use in medical diagnosis and pharmaceutical testing within the next decade and a range of cell based biosensors. 

The recovery period after drug exposure is important for many reasons. This period permits the re-establishment of metabolic equilibrium when inhibition is used as a pharmaceutical test. In addition, cells can recover from sublethal damage or indicate effects of late cytotoxicity, which are not revealed in alternative tests. 

This analysis shows that the within-experiment coefficient of variation is also independent of any one of four pharmaceuticals tested over a nine-month period consisting of 367 separate diffusion cell analyses. 

Our results further show that the variability is not significantly different among four different pharmaceuticals tested and among four different technicians conducting these experiments. The computer interfaced data collection and data reduction network allows the completion of a 28 cell diffusion experiment in less than 25 hours with minimal labor. 

Environmental Growth Chambers (25) PST-19 Photostability Chamber, Figure 8, is designed to complete ICH QIB, Option 2 compliant pharmaceutical testing in as little as 20 hours. It has four shelves having a combination of UV-A and VIS bulbs and each shelf s bulb type is independently controlled. The air-flow to each shelf is independently controllable with dampers. 

Figure 19 (A) QUV/cw, cool white photostability tester (B) a cross sectional view of the test chamber before modification for pharmaceutical testing and (C) their tablet sample holder tor the unit. Source. Courtesy of Q-Lab Corporation.

Samples from the finished product for conducting pharmaceutical tests and reference substances necessary for conducting the trials in accordance with the product specifications. 

Pharmaceutical testing is described as an analytical procedure for checking the quality and active ingredients of drugs. 

Specifications for the finished product Two specifications at release and end of shelf-life List general characteristics, specific standards tests and limits for results for the finished product must be provided Analytical test procedures described (physicochemical properties, identity of API) Quantitative determination of active, deviations, purity tests, pharmaceutical tests, colouring antimicrobial or chemical preservatives, results of validation studies, comments on the choice of routine tests and standards provided Copy of pharmacopoeia monograph and verification data Results of batch analysis (inc. date of manufacture, place of manufacture, batch size and use of batch tested) ... 

This chapter reviews the use of HPLC in pharmaceutical analysis from drug discovery to quality control. The focus is on HPLC analysis of drug substances (DS) and products (DP) such as assay for potency, purity evaluation, and dissolution testing. A case study of the various HPLC methods used during early clinical development illustrates the versatility of this technique. Detailed descriptions of HPLC applications in pharmaceutical development and LC/MS analysis in drug discovery and bioanalytical studies can be found elsewhere.1-6 The regulatory aspects in pharmaceutical testing are covered in Chapter 9. 

J.Cooper, Plastic Containers for Pharmaceuticals. Testing and Control. WHO, Geneva, 1974. 

J. E. Kipp and J. J. Hlavaty, Nonisothermal stability assessment of stable pharmaceuticals Testing of a clinamycin phosphate formulation, Pharm. Res. 8, 570-575 (1991). 

The 2-chloroquinoxaline 3-, 6-, or 7-carbonyl moiety has been incorporated into various dyes, and 2-chloroquinoxaIine is used in the preparation of substituted piperidines" and indoles" for pharmaceutical testing. 

Cooper J.F. (1985) Ideal propertie.sof a LAL reagent for pharmaceutical testing. In Bacterial endotoxins structure, biomedical significance, and detection with the Limulus amebocyte lysate test. Alan R. Liss. Inc.. New York, 241-249. 

---